232 related articles for article (PubMed ID: 31768692)
1. Prognostic value of alkaline phosphatase in hormone-sensitive prostate cancer: a systematic review and meta-analysis.
Mori K; Janisch F; Parizi MK; Mostafaei H; Lysenko I; Enikeev DV; Kimura S; Egawa S; Shariat SF
Int J Clin Oncol; 2020 Feb; 25(2):247-257. PubMed ID: 31768692
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Lactate Dehydrogenase in Metastatic Prostate Cancer: A Systematic Review and Meta-analysis.
Mori K; Kimura S; Parizi MK; Enikeev DV; Glybochko PV; Seebacher V; Fajkovic H; Mostafaei H; Lysenko I; Janisch F; Egawa S; Shariat SF
Clin Genitourin Cancer; 2019 Dec; 17(6):409-418. PubMed ID: 31558410
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of Hemoglobin in Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Meta-analysis.
Mori K; Janisch F; Mostafaei H; Lysenko I; Karakiewicz PI; Enikeev DV; Briganti A; Kimura S; Egawa S; Shariat SF
Clin Genitourin Cancer; 2020 Aug; 18(4):e402-e409. PubMed ID: 32007439
[TBL] [Abstract][Full Text] [Related]
4. The Prognostic Impact of Intraductal Carcinoma of the Prostate: A Systematic Review and Meta-Analysis.
Miura N; Mori K; Mostafaei H; Quhal F; Motlagh RS; Pradere B; Laukhtina E; D'Andrea D; Saika T; Shariat SF
J Urol; 2020 Nov; 204(5):909-917. PubMed ID: 32698712
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model.
Gravis G; Boher JM; Fizazi K; Joly F; Priou F; Marino P; Latorzeff I; Delva R; Krakowski I; Laguerre B; Walz J; Rolland F; Théodore C; Deplanque G; Ferrero JM; Pouessel D; Mourey L; Beuzeboc P; Zanetta S; Habibian M; Berdah JF; Dauba J; Baciuchka M; Platini C; Linassier C; Labourey JL; Machiels JP; El Kouri C; Ravaud A; Suc E; Eymard JC; Hasbini A; Bousquet G; Soulie M; Oudard S
Eur Urol; 2015 Aug; 68(2):196-204. PubMed ID: 25277272
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of Pretreatment Albumin-to-Alkaline Phosphatase Ratio in Cancer: A Meta-Analysis.
Xie H; Wei L; Tang S; Gan J
Biomed Res Int; 2020; 2020():6661097. PubMed ID: 33376729
[TBL] [Abstract][Full Text] [Related]
7. Serum Prognostic Factors of Androgen-deprivation Therapy Among Japanese Men With
Kobayashi T; Namitome R; Hirata YU; Shiota M; Imada K; Kashiwagi E; Takeuchi A; Inokuchi J; Tatsugami K; Eto M
Anticancer Res; 2019 Jun; 39(6):3191-3195. PubMed ID: 31177166
[TBL] [Abstract][Full Text] [Related]
8. Albumin-to-alkaline phosphatase ratio as a promising indicator of prognosis in human cancers: is it possible?
An L; Yin WT; Sun DW
BMC Cancer; 2021 Mar; 21(1):247. PubMed ID: 33685425
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of miR-21 for prostate cancer: a systematic review and meta-analysis.
Stafford MYC; Willoughby CE; Walsh CP; McKenna DJ
Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34931228
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of alkaline phosphatase and bone-specific alkaline phosphatase in breast cancer: A systematic review and meta-analysis.
Jiang C; Hu F; Xia X; Guo X
Int J Biol Markers; 2023 Mar; 38(1):25-36. PubMed ID: 36775971
[TBL] [Abstract][Full Text] [Related]
11. Prognostic effect of pretreatment albumin-to-alkaline phosphatase ratio in human cancers: A meta-analysis.
Guo X; Zou Q; Yan J; Zhen X; Gu H
PLoS One; 2020; 15(8):e0237793. PubMed ID: 32822383
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of serum alkaline phosphatase in the survival of prostate cancer: evidence from a meta-analysis.
Li D; Lv H; Hao X; Hu B; Song Y
Cancer Manag Res; 2018; 10():3125-3139. PubMed ID: 30214305
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Significance of Serum Alkaline Phosphatase Level in Osteosarcoma: A Meta-Analysis of Published Data.
Ren HY; Sun LL; Li HY; Ye ZM
Biomed Res Int; 2015; 2015():160835. PubMed ID: 26618165
[TBL] [Abstract][Full Text] [Related]
14. Does serum alkaline phosphatase level really indicate the prognosis in patients with osteosarcoma? A meta-analysis.
Gu R; Sun Y
J Cancer Res Ther; 2018 Jun; 14(Supplement):S468-S472. PubMed ID: 29970708
[TBL] [Abstract][Full Text] [Related]
15. Revealing Prognostic Value of Skeletal-Related Parameters in Metastatic Castration-Resistant Prostate Cancer on Overall Survival: A Systematic Review and Meta-Analysis of Randomized Controlled Trial.
Tong T; Lei H; Guan Y; Yang X; Liao G; Li Y; Jiang D; Pang J
Front Oncol; 2020; 10():586192. PubMed ID: 33330067
[TBL] [Abstract][Full Text] [Related]
16. Implications of serum bone turnover markers in prostate cancer patients with bone metastasis.
Kamiya N; Suzuki H; Yano M; Endo T; Takano M; Komaru A; Kawamura K; Sekita N; Imamoto T; Ichikawa T
Urology; 2010 Jun; 75(6):1446-51. PubMed ID: 20206975
[TBL] [Abstract][Full Text] [Related]
17. The prognostic impact of decreased pretreatment haemoglobin level on the survival of patients with lung cancer: a systematic review and meta-analysis.
Huang Y; Wei S; Jiang N; Zhang L; Wang S; Cao X; Zhao Y; Wang P
BMC Cancer; 2018 Dec; 18(1):1235. PubMed ID: 30526532
[TBL] [Abstract][Full Text] [Related]
18. The flare in serum alkaline phosphatase activity after orchiectomy: a valuable negative prognostic index for progression-free survival in prostatic carcinoma.
Pelger RC; Lycklama A Nijeholt GA; Zwinderman AH; Papapoulos SE; Hamdy NA
J Urol; 1996 Jul; 156(1):122-6. PubMed ID: 8648772
[TBL] [Abstract][Full Text] [Related]
19. Prediction of survival of metastatic prostate cancer based on early serial measurements of prostate specific antigen and alkaline phosphatase.
Robinson D; Sandblom G; Johansson R; Garmo H; Stattin P; Mommsen S; Varenhorst E;
J Urol; 2008 Jan; 179(1):117-22; discussion 122-3. PubMed ID: 17997442
[TBL] [Abstract][Full Text] [Related]
20. Audit and its impact in the management of advanced prostatic cancer.
Rana A; Chisholm GD; Christodoulou S; McIntyre M; Elton RA
Br J Urol; 1993 Oct; 72(4):478-83. PubMed ID: 8261306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
